Table 4.
Racial differences in the use of standard adjuvant chemotherapy and timing of chemotherapy administration.
| Total | White | African American | P value | ||
|---|---|---|---|---|---|
| Standard regimena | |||||
| No | 210 (26.2%) | 128 (25.9%) | 82 (26.6%) | ||
| Yes | 593 (73.8%) | 367 (74.1%) | 226 (73.4%) | 0.811 | |
| Time to chemotherapyb | |||||
| 0–60 days | 405 (50.4%) | 274 (55.4%) | 131 (42.5%) | ||
| >60 days | 398 (49.6%) | 221 (44.7%) | 177 (57.5%) | <0.001 | |
| Completed the recommended number of cycles or morea,c | |||||
| No | 172 (29.0%) | 106 (28.9%) | 66 (29.2%) | ||
| Yes | 421 (71.0%) | 261 (71.1%) | 160 (70.8%) | 0.933 | |
aStandard regimen as defined by the NCCN guidelines as of the date of breast cancer diagnosis.
bTime to chemotherapy based on the time period from date of diagnosis to the date of initiation of adjuvant chemotherapy.
cCalculated only for women who received a standard regimen.